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Allergy is a exacerbate response of immune system to a triggering element. A probable cause of 
allergies is gut microbiota composition. It has strong relationship with development of human 
immune system and this is formed in intrauterine life and early childhood, crucial periods for 
formation adequate microbiota. In this sense modulation gut microbiota by probiotics could 
prevent or help in the treatment of allergic diseases such as allergic rhinitis, asthma, atopic 
dermatitis and food allergy. Studies published to date are controversial. It is difficult to determine 
whether the probiotic can be used in the treatment and prevention of allergic diseases. 
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La alergia es una respuesta exacerbada del sistema inmunitario a un elemento desencadenante. 
Una probable causa de las alergias es la composición del microbioma intestinal. Tiene una fuerte 
relación con el desarrollo del sistema inmunitario humano y se forma en la vida intrauterina y 
en la primera infancia, períodos cruciales para la formación de la microbiota adecuada. En este 
sentido, la modulación de la microbiota intestinal por los probióticos podría prevenir o ayudar 
en el tratamiento de enfermedades alérgicas como la rinitis alérgica, el asma, la dermatitis ató-
pica y la alergia alimentaria. Los estudios publicados hasta la fecha son controvertidos. Es difícil 
determinar si los probióticos pueden usarse en el tratamiento y prevención de enfermedades 
alérgicas. 
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INTRODUCTION
Allergy is a hypersensitivity reaction initiated by 
immunological mechanisms. It can be mediated by 
antibodies or cells1. Prevalence of allergy is increasing 
worldwide2 such as atopic dermatitis, food allergies, allergic 
rhinitis and asthma, and childhood is the phase of the 
begining3. The allergic phenotype is due to the combination 
of two elements: genetic predisposition and environmental 
factors interacting with genes4.
Hygiene hypothesis may be possible explanation for the 
increased diagnosis of allergies. It is believed that the 
increase in care of cleaning and hygiene, reducing the 
number of family members and reduction of childhood 
infections decrease bacterial exposure, which is crucial for 
the development of the immune system in early life5. The 
lack of contact with bacteria in childhood means that there 
is absence in the conversion of T help 1 (Th1) to Th2, thereby 
making the individual more susceptible to allergy6.
Recently it has been proposed that bacteria habiting the 
human body, in particular gut microbiota, is associated 
with the allergic process by possessing an important role in 
the construction of the mucosal immune tolerance7. Recent 
evidence shows that the colonization of microbiota occurs 
during pregnancy at intrauterine life, through contact of 
maternal microbiota with the fetus through the placenta 
and amniotic fluid8.
Some points are critical in the formation of microbiota and, 
hence the immune system, such as type of delivery and 
lactation. Vaginal birth allows the baby have to contact with 
maternal microbiota8,9. In addition breastfeeding plays a 
key role in the development of newborn microbiota. Studies 
show that children breastfed contain higher amounts of 
bifidobacteria in the microflora8. Childhood period is where 
gastrointestinal tract (GIT) undergoes greater influence 
of environmental factor and it is completely established 
between 2 and 3 years of age. For this reason, this stage 
of life is crucial for the proper development of the immune 
system10.
The formation of microbiota is important in development 
of host defenses against gastrointestinal infections and 
allergic reactions. Bacteria interact with cells of immune 
system helping the maturation of these11. A study compared 
the development of immune system in germ-free mice, 
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avoid the animals and feathers, keep always clean and 
airy environment. The second is the use of drugs such as 
antihistamines that inhibits the main allergy mediator; 
decongestants, promote vasodilation; corticosteroids, 
control protein synthesis, reducing production of 
inflammatory mediators17.
Atopic dermatitis, also called of atopic eczema, is a chronic 
disease with clinical manifestations cutaneous. It is 
originated from the genetic predisposition of the immune 
system to emphasize IgE-mediated hypersensitivity in 
response to allergic food and environment. Diagnosis 
is made by the clinical picture of the disease18. Drugs 
can be used, such as topical steroids, which have anti-
inflammatory effect by inhibiting the action of dendritic 
cells (DC) and lymphocytes; immunomodulators or topical 
calcineurin inhibitors, which reduce inflammation; systemic 
immunosuppression indicated for severe cases that do not 
respond to previous treatments19.
Food allergy occurs when an abnormal response is given 
to food or food additive exposure20,21. It may be toxic, which 
depends on the ingested food or non-toxic dependent on 
individual predisposition, being or not immune mediated21. 
Diagnosis is made by medical history of the individual 
and it may be supplemented by laboratory tests, such 
as determination of specific IgE. Skin tests of immediate 
hypersensitivity and oral trigger, which is the reliable test 
to diagnose food allergy. This test consists of exposing the 
individual to food that is likely to have allergies. Treatment 
is based on combination of exclusion of food that causes the 
allergy and drugs that treat allergy symptoms. Among the 
drugs may be mentioned self-injectable adrenaline, may be 
used in case of accidental ingestion of food to which it is 
allergic, when associated anaphylaxis; antihistamines for 
relief of symptoms of oral allergy syndrome and cutaneous 
symptoms mediated by IgE; systemic corticosteroids, which 
triggered reverse the inflammatory symptoms20,21. 
 
MICROBIOTA AND IMMUNE SYSTEM
GIT is composed by microorganisms forming microbiota, 
which has role in various metabolic activities of host. 
Microbiota may to help absorption of nutrients, fermentation 
food, stimulation of the host immune system and protection 
against pathogens22. 
The colonization of the host begins in intrauterine life 
through of maternal microbiota contact by placenta and 
amniotic fluid with fetus8. Some points are crucial for 
colonization with beneficial bacteria, among which can 
which have not microbiota, and conventional mice. Authors 
found immune system undeveloped in germ-free mice, with 
reduction of intra epithelial lymphocyte number and small 
size of Peyer’s patches, change in the structure of the crypts 
and reducing the thickness of the mucus12.
Probiotics are live microorganisms able to improve the 
microbial balance producing beneficial health effects of the 
individual13. Probiotics have revealed adjuvant effects on 
immune response12. They can modulate the gastrointestinal 
physiology of the host by improving mucosal immunity 
and intestinal permeability14. Thus, the stimulation and 
maintenance of normal microbiota can increase the 
beneficial bacterial population, resulting in health of GIT 
with regular consumption of probiotic bacteria15.
The objective of this study was to evaluate the use of 
probiotics on prevention and treatment of allergic diseases 
as atopic dermatitis, allergic rhinitis and asthma, and food 
allergy. 
ALLERGIES: ASTHMA, ALLERGIC 
RHINITIS, ATOPIC DERMATITIS AND 
FOOD ALLERGY
Allergy is characterized by increased capacity of B 
lymphocytes producing immunoglobulin E (IgE) against 
antigens that enter the body via the airways, skin or GIT. 
Among allergic diseases can be mentioned atopic dermatitis, 
asthma, allergic rhinitis and food allergy1.
Asthma is a chronic inflammation of the lower airways 
coming from eosinophils and hyperresponsiveness. It is 
characterized by coughing, wheezing and dyspnea. This 
disease is triggered when individual is exposed to elements 
that initiate inflammation in bronchi, limiting the flow of 
air in the lungs. Diagnosis is based on history of a disease, 
clinical examination, pulmonary function and allergy 
evaluation16. Treatment is indicated to prevent and reduce 
contact allergenic elements; moreover, some drugs can be 
used, as such:  β2-adrenergic, theophylline, anticholinergics, 
and corticosteroids. 
Allergic rhinitis is a chronic symptomatic nasal disorder 
triggered by exposure to allergies such as dust, cold air, 
smoke, odors and pollutants which cause IgE-mediated 
inflammation in the nasal mucosa. Diagnosis is made 
by clinical and family history of atopy and, physical and 
laboratory tests. Treatment of disease can be divided 
into non-drug and drug. The first include control of 
allergenic components, reducing objects that may favor 
the accumulation of dust, such as carpets, curtains, etc., 
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the composition of microbiota associated with allergic 
processes, and identified difference between children with 
or without allergy. They noted that children with allergy had 
lower biodiversity in microbiota composition32. 
PROBIOTICS AND IMMUNE SYSTEM 
Probiotics could be from human origin and undergo a 
selection considering the following criteria: gender (source, 
definition, characterization and safe species), stability and 
security (activity and viability in products; adherence; have 
resistance to low pH and gastric juices, bile and pancreatic; 
and colonizing ability) and functional and physiological 
aspects (adhesion to intestinal epithelium, antagonism to 
pathogens, stimulation or suppression of immune response 
and stimulating beneficial bacteria)33. 
Probiotics have the ability to modulate the digestive 
physiology of the host, altering mucosal immunity and gut 
permeability14. Thus, it has been studied how to maintain 
a healthy microbiota to obtain benefits to the host. 
Furthermore, the daily consumption of probiotic favors the 
growth of commensal bacteria, thereby reducing pathogens, 
resulting in health GIT15.
The positive effects that these bacteria have on the GIT 
microbiota occur through antagonistic effects of competition 
and immunological favoring the gut commensal bacteria, 
intensified, so natural defenses of host. These effects occur 
through three possible mechanisms. The first is by deletion 
of viable cells by competition of nutrients, adhesion cells, 
production of antimicrobial substances lactic acid, which 
is able to reduce the intestinal pH, preventing growth 
of bacteria sensitive to acidic environments, which most 
often are pathogenic. Since the antibacterial substances 
kill pathogenic bacteria affecting essential enzymes or cell 
membrane. In the second microbial metabolism is altered, 
increasing or decreasing enzyme activity. The third through 
stimulating host immunity with increased circulating 
antibodies and macrophage activity34.
Compounds of cell wall, DNA and metabolites of 
probiotics may manipulate the immune system because 
the host enterocytes have receptors that recognize these 
bacteria, which bind triggering a signaling cascade and 
modulating the immune function of the individual. The 
probiotics modulate immunity through the induction of 
proinflammatory cytokines and increased production of 
secretory35.
be highlighted childbirth and lactation. Vaginally delivery 
exposes children to bacteria maternal microbiota8,9. 
Breastfeeding promotes colonization of the infant 
microbiota with bifidobacteria8. A study that compared 
microbiota composition of breastfed babies and those 
fed with infant formula found that breastfed had greater 
variety of Bifidobacterium in the composition of their gut 
microbiota23. Two-three years old is essential to microbiota 
because in this period microbiota suffers a major impact of 
environmental factors24.
The colonization of gut microbiota is essential for proper 
development of innate and adaptive immune system. It has 
been found that the colonization of microbiota is critical 
to the maturation of Th1 and regulatory T (Treg) during 
childhood25, and assist in the development of gut associated 
lymphoid tissue (GALT) and IgA production26. Studies in 
animal models comparing immune system of germ-free 
rats and conventional showed that the germ-free has major 
defects in the immune system with Peyer’s patches in 
quantity and reduced size and fewer lymph nodes centers in 
the mesentery12. Another experimental study on germ-free 
mice noted that microbiota is important to develop GALT 
and function of epithelial barrier27. Studies were performed 
in which colonization by bacteria in gut of germ-free rats 
found restoration of the immune system in this animals28.
Immune system is developed with gut microbiota to 
ensure homeostasis and symbiosis. When commensal and 
pathogenic bacteria are in balance, there is a constant 
stimulus in secretion defense mediators by gut epithelial 
cells such as 3γ protein derived islet for regeneration 
(REGII3γ), lymphopoietin thymic stromal (TSLP ), interleukin 
33 (IL-33), IL-25 and tumor growth factor-β (TGF-β), which 
are responsible for the tolerability of macrophages and 
DC28,29. DC stimulates the formation of Treg cells by TGF-β 
and retinoic acid, which associated with macrophages 
and DC are capable of generating an anti-inflammatory 
environment in the gut lumen29. Moreover, there is IgA 
production by TGF-β to cell activation30.
In the dysbiosis, which there is an imbalance between 
commensal and pathogenic bacteria, creating an 
inflammatory environment, the molecular pattern 
associated with microbes is increasing, and this stimulates 
gut epithelial cells differently, activating DC, macrophages 
and secrete inflammatory cytokines. This latter stimulate 
Th1 and Th17 culminating in chronic inflammation. Th17 
together with the innate immune system cells producing IL-
22, which promotes the expression of REGIIIγ and REGIIIβ, 
thus interfering in the intestinal microbiota31.
In this feeling composition of microbiota plays an important 
role in allergy development. A systematic review evaluated 
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symptoms41. Another meta-analysis did not show beneficial 
effect on prevention of the development of asthma in 
children after use of probiotic during pregnancy and early 
life42.
The literature shows the probiotic as potential effects 
preventive of atopic dermatitis. Two meta-analysis indicated 
the use of probiotic as important role in prevention of atopic 
dermatitis43,44. Its use can be in intrauterine life or after birth, 
including population general and that in risk of allergic44.   
On the other hand, another study this type showed improves 
on atopic dermatitis in children and adults individual. The 
authors suggested the use of probiotic in treatment of this 
allergy45. This contradictory result when comparing with 
meta-analysis cited before could be the population of study. 
A randomized clinical trial administered fermented milk 
containing 3x109 CFU of L. acidophilus L-92 in children 4-15 
years old for 8 weeks. They observed that the probiotic had 
potential to improve symptoms in atopic dermatitis46. Han 
et al.47 showed effect on treatment of atopic dermatitis in 
children (18 moths-13 years old) when used 0.5x1010 CFU 
L. plantarum CJLP133 twice a day during 12 weeks. Another 
clinical trial with children aged 1-13 years old consuming a 
mix of probiotic (Bifidobacterium bifidum, L. acidophilus, L. casei, 
and L. salivarius) by 8 weeks found improves in SCORAD index 
for this disease and any cytokines and IgE48.
PROBIOTICS IN FOOD ALLERGY
There are not many studies conducted in humans to 
evaluate the effects of different probiotic strains on signs 
and symptoms allergic to certain foods, which makes it 
more difficult to determine whether the use of probiotics 
could help in treatment of this allergy. 
A recent meta-analysis assessed whether probiotics can 
prevent the development of food allergies in children, 
but could not determine if probiotics are beneficial in this 
regard49. A recent randomized controlled trial evaluated the 
use of probiotic L. rhamnosus CGMCC 13724 (2x1010 CFU) as 
adjuncts in the treatment of oral immunotherapy in children 
with peanut allergy and found that there was no allergic 
response to food50.
PROBIOTICS IN ATOPIC DERMATITIS
In vitro studies show the effects of probiotic exerted on the 
immune system of the host. These bacteria have the ability 
to stimulate specific and nonspecific immune response 
by activation of macrophages and increase of cytokines, 
natural killer cells, IgA and T lymphocytes35. Braat et al.36 
observed that supplementation of Lactobacillus rhamnosus 
for 2 weeks is capable of modulating T cell responsiveness 
in vivo and found that the probiotic was able to modulate DC 
inducing T cell hyporesponsiveness.
Humans and animals studies have showed probable 
mechanisms of probiotics in modulation of immune 
system of the host. They act repairing and maintaining the 
mucosal barrier, which reduces gut permeability; increases 
TGF-β and prostaglandin E2 production in enterocytes, 
thereby reducing translocation of allergy, enhancing local 
inflammation and promote tolerance; anti-inflammatory 
effect through toll-like receptor 9 by inhibiting Th2-type 
allergic response; DC increased activity in the intestine, 
which leads to tolerance of these cells; increase in Th1 
response with consequent reduction in differentiation 
of Th2 response; IL-10 production and TGF-β to enhance 
oral tolerance via DCs, IgA and Treg; increase in lymphoid 
tissue that generates tolerogenic effect; increase in Th1 
differentiation and IgA production in other tissues due to 
effects of GIT T and B cells , respectively37.
PROBIOTICS IN RESPIRATORY 
ALLERGIES
A systematic review evaluated randomized controlled 
trials testing use of probiotics on allergic respiratory 
diseases such as asthma and allergic rhinitis, and found 
that most studies indicated beneficial effects of probiotics 
in treatment of rhinitis and reduced severity of symptoms, 
thereby reducing the use of medications38. However they do 
not define possible probiotics strains and doses benefices. 
On the other hand, a meta-analysis including studies with 
intervention of probiotic in asthma and rhinitis allergic did 
not observe beneficial effect of probiotic on these diseases39. 
A double blind randomized controlled study administered 
108 CFU of L. reuteri in women during pregnancy and their 
children from birth until 12 months old and accompanied 
the children until seven years old. There was not reduction 
in the prevalence of respiratory allergy in preschool period40.
A recent meta-analysis evaluated whether probiotics can 
prevent and treat allergic rhinitis. There is not claim that 
probiotics should be used in the treatment and prevention 
of disease, although having showed improve overall in 
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A randomized clinical trial conducted with children between 
3 and 12 months old administered 1x109 CFU B. animalis 
subsp. lactis BB-12 and 1x108 CFU Streptococcus thermophilus 
TH-4 for a period of 8 weeks and evaluated its effects on 
gastrointestinal symptoms of allergy to cow’s milk. They 
found that the group receiving the probiotic associated 
with conventional treatment for allergy to cow’s milk 
had improved gastrointestinal symptoms and lower 
gastrointestinal clinical manifestations resulting from 
allergy to milk51.
CONCLUSIONS
Studies have showed conflicting results, which may be due 
to different methods, doses and strains used in the work, 
hindering the determination of strain and the quantity that 
could assist in the treatment and prevention of allergic 
diseases. However, probiotics seem to have promising 
effects in supporting of treatment and prevention of 
allergic diseases, principally respiratory allergies and atopic 
dermatitis. Well-conducted studies evaluating the use of 
probiotics in children with allergies should be performed to 
find out the strains that can be used to treat this disease. 
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